T Cell Activation

Houston, Texas, USA, November 5, 2026 ImmunoGenesis, a clinical-stage biotechnology company focused on developing innovative cancer immunotherapies, has announced...

Copenhagen, Denmark, and New York, United States, October 28, 2026 HERVolution Therapeutics, a biotechnology company developing human endogenous retrovirus...

WATERTOWN, Mass. — September 25, 2026 C4 Therapeutics presented new biomarker data from clinical trials of cemsidomide in patients...

San Diego, California, U.S., September 8, 2026 Inhibrx Biosciences, Inc. has reported positive primary endpoint results from the randomized...